StockWatch
·

LINCOLN PHARMACEUTICALS LTD. Q2 FY26 Results

LINCOLNQ2 FY26 Results
Filing
MetricValue ( Cr)Q1 FY26Q2 FY25
Revenue163.366.0%1.3%
Total Income170.600.7%0.3%
Expenditure141.795.8%3.9%
PBT28.8118.6%17.2%
Net Profit19.9827.8%24.1%
OPM15.57%0.12pp2.40pp
NPM11.71%4.63pp3.67pp
EPS9.9827.8%24.1%
View full financials

Informational and educational content only. Not investment advice.